CME Group Inc.CMENASDAQ
Loading
CME Revenue Growth (YoY Quarterly)•+8.09%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+8.09%
+11.0pp
+7.90%
+12.7pp
+30.25%
+30.1pp
+7.65%
+12.7pp
+33.55%
+34.1pp
+35.42%
+36.2pp
+35.00%
+35.4pp
+0.07%
-0.0pp
+0.05%
-0.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.98% | +10.38% | +10.41% | -2.95% | +8.09% |
| Gross Profit Growth | +6.37% | +11.99% | +10.74% | -4.80% | +7.90% |
| EBITDA Growth | +7.84% | +10.53% | +13.99% | +0.20% | +30.25% |
| Operating Income Growth | +9.72% | +15.46% | +12.86% | -5.04% | +7.65% |
| Net Income Growth | +7.37% | +11.81% | +14.61% | -0.53% | +33.55% |
| EPS Growth | +7.14% | +11.91% | +15.64% | -0.80% | +35.42% |
| EPS Diluted Growth | +7.14% | +11.49% | +16.12% | -0.40% | +35.00% |
| Weighted Average Shares Growth | +0.05% | +0.10% | +0.09% | +0.07% | +0.07% |
| Weighted Average Shares Diluted Growth | +0.10% | +0.11% | +0.12% | +0.09% | +0.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -2.53% | +25.08% | +36.25% | -3.48% | +210.49% |
| Free Cash Flow Growth | -3.11% | +26.29% | +37.09% | -2.41% | +218.70% |
| Receivables Growth | +7.00% | +22.60% | +11.36% | +2.14% | +11.53% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +5.97% | +19.52% | +45.82% | +35.81% | +44.36% |
| Book Value per Share Growth | -0.99% | -0.55% | +0.29% | -0.16% | +8.39% |
| Debt Growth | +0.08% | -0.19% | -0.18% | -0.18% | -0.17% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -6.09% | -13.90% | +7.78% | +18.39% | +41.30% |
1 / 4